Department of Orthopaedics & Rehabilitation, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
Duke Orthopaedic Surgery, Duke University, Durham, North Carolina, USA.
Am J Sports Med. 2021 May;49(6):1530-1537. doi: 10.1177/0363546521999419. Epub 2021 Apr 2.
Optimal treatment of meniscal pathology continues to evolve in orthopaedic surgery, with a growing understanding of which patients benefit from which procedure and which patients might be best treated nonsurgically. In 2002, Moseley et al found no difference between arthroscopic procedures, including meniscal debridement and sham surgery, in patients with osteoarthritis of the knee. This called into question the role of routine arthroscopic debridement in these patients. Additionally, an increased interest in understanding and maintaining the function of the meniscus has more recently resulted in a greater focus on meniscal preservation procedures.
Descriptive epidemiology study.
PURPOSE/HYPOTHESIS: The purpose was to evaluate the trends of arthroscopic meniscal debridement and repair and the characteristics of the patients receiving these treatments, compare the differences in practice between newly trained orthopaedic sports medicine specialists and those of other specialties, and analyze if there are differences in practice by region. It was hypothesized that the American Board of Orthopaedic Surgery (ABOS) database would evaluate practice patterns of recent graduates as a surrogate for current treatment and training and, consequently, demonstrate a decreased rate of meniscal debridement.
Data from ABOS Part II examinees from 2001 to 2017 were obtained from the ABOS Case List. Current Procedure Terminology (CPT) codes related to arthroscopic meniscal treatment were selected. The examination year, age of the patient, practice region, and examinee subspecialty were analyzed. Patient age was stratified into 4 groups: <30, 30 to 50, 51 to 65, and >65 years. Examinee subspecialty was stratified into sports medicine and non-sports medicine. Statistical regression analysis was performed.
Between 2001 and 2017, ABOS Part II examinees submitted 131,047 cases with CPT codes 29880 to 29883. Meniscal debridement volume decreased for all age groups during the study period, while repair increased. Sports medicine subspecialists were more likely than their counterparts to perform repair over debridement in patients aged younger than 30 years ( = .0004) and between 30 and 50 years ( = .0005).
This study provides insights into arthroscopic meniscal debridement and repair practice trends among ABOS Part II examinees. Meniscal debridement is decreasing and meniscal repair is increasing. Younger patient age and treatment by a sports medicine subspecialty examinee are associated with a higher likelihood of repair over debridement.
在骨科手术中,半月板病理的最佳治疗方法不断发展,人们越来越了解哪些患者受益于哪种治疗方法,哪些患者最好采用非手术治疗。2002 年,Moseley 等人发现膝关节骨关节炎患者的关节镜手术(包括半月板清创术和假手术)之间没有差异。这对这些患者常规关节镜清创术的作用提出了质疑。此外,最近人们对了解和维持半月板功能的兴趣增加,导致更加关注半月板保留手术。
描述性流行病学研究。
目的/假设:目的是评估关节镜下半月板清创术和修复术的趋势,以及接受这些治疗的患者的特征,比较新培训的骨科运动医学专家和其他专业医生之间的实践差异,并分析区域差异。假设美国骨科外科医师学会(ABOS)数据库将评估最近毕业生的实践模式作为当前治疗和培训的替代指标,因此,半月板清创术的比例将会降低。
从 ABOS 病例清单中获取 2001 年至 2017 年 ABOS 第二部分考试的考生数据。选择与关节镜半月板治疗相关的当前程序术语(CPT)代码。分析考试年份、患者年龄、实践区域和考生专科。患者年龄分为 4 组:<30 岁、30 至 50 岁、51 至 65 岁和>65 岁。考生专科分为运动医学和非运动医学。进行统计回归分析。
在 2001 年至 2017 年期间,ABOS 第二部分考生提交了 131047 例 CPT 代码为 29880 至 29883 的病例。在研究期间,所有年龄组的半月板清创术量都减少了,而修复术量增加了。在<30 岁和 30 至 50 岁的患者中,运动医学专科医生比其他专科医生更有可能进行半月板修复而不是清创术(=0.0004)。
本研究提供了有关 ABOS 第二部分考生关节镜下半月板清创术和修复术实践趋势的见解。半月板清创术正在减少,半月板修复术正在增加。年轻患者年龄和运动医学专科医生的治疗与半月板修复术而非清创术的可能性更高相关。